Angela Gause

1.8k total citations
65 papers, 1.2k citations indexed

About

Angela Gause is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angela Gause has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 23 papers in Rheumatology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angela Gause's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Lymphoma Diagnosis and Treatment (16 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Angela Gause is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Lymphoma Diagnosis and Treatment (16 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Angela Gause collaborates with scholars based in Germany, United States and Canada. Angela Gause's co-authors include Michael Pfreundschuh, Klaus Rajewsky, Volker Diehl, Jan Voswinkel, Wolfgang L. Gross, H. Daus, Ralf Küppers, Peter Lamprecht, W. Jung and Dirk Hasenclever and has published in prestigious journals such as Blood, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Angela Gause

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Gause Germany 22 504 415 296 288 279 65 1.2k
Norihito Yazawa Japan 25 585 1.2× 814 2.0× 440 1.5× 194 0.7× 333 1.2× 55 1.6k
S Pileri Italy 17 180 0.4× 449 1.1× 178 0.6× 212 0.7× 179 0.6× 36 1.3k
TC Diss United Kingdom 22 273 0.5× 968 2.3× 207 0.7× 268 0.9× 333 1.2× 32 1.5k
Jeffrey J. Wisnieski United States 18 639 1.3× 309 0.7× 733 2.5× 286 1.0× 156 0.6× 36 1.3k
Giorgio Inghirami United States 16 640 1.3× 308 0.7× 150 0.5× 180 0.6× 50 0.2× 28 1.3k
A Marmont Italy 16 901 1.8× 320 0.8× 213 0.7× 331 1.1× 100 0.4× 43 2.1k
AA Morley Australia 16 288 0.6× 743 1.8× 87 0.3× 462 1.6× 128 0.5× 23 1.5k
AJ Norton United Kingdom 15 314 0.6× 1.2k 2.9× 88 0.3× 334 1.2× 287 1.0× 19 1.7k
A S Krajewski United Kingdom 24 412 0.8× 986 2.4× 185 0.6× 204 0.7× 100 0.4× 57 1.7k
Margaret Ashton‐Key United Kingdom 21 427 0.8× 473 1.1× 62 0.2× 303 1.1× 190 0.7× 44 1.3k

Countries citing papers authored by Angela Gause

Since Specialization
Citations

This map shows the geographic impact of Angela Gause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Gause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Gause more than expected).

Fields of papers citing papers by Angela Gause

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Gause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Gause. The network helps show where Angela Gause may publish in the future.

Co-authorship network of co-authors of Angela Gause

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Gause. A scholar is included among the top collaborators of Angela Gause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Gause. Angela Gause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubbert‐Roth, Andrea, et al.. (2014). Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis. Zeitschrift für Rheumatologie. 73(2). 165–174. 4 indexed citations
2.
Goldacker, Sigune, et al.. (2013). Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen. Zeitschrift für Rheumatologie. 72(7). 690–704. 13 indexed citations
3.
Gause, Angela, Uğur Şahin, & Michael Pfreundschuh. (2008). Neue Perspektiven in der Immuntherapie: Adhäsionsmoleküle, Superantigene, Hitze-Schock-Proteine und Zytokinantagonisten. DMW - Deutsche Medizinische Wochenschrift. 117(46). 1764–1773.
4.
Aries, Peer & Angela Gause. (2008). Vaskulitis. Zeitschrift für Rheumatologie. 68(1). 44–48.
5.
Krämer, Jan, Andreas Müller, Karen Herlyn, et al.. (2007). B-Lymphozyten-Differenzierung in granulomatösen Geweben der Lunge und der Nasenschleimhäute beim Morbus Wegener. Zeitschrift für Rheumatologie. 66(5). 421–429. 3 indexed citations
6.
Ito, Satoshi, Wolfgang L. Gross, E. Reinhold‐Keller, et al.. (2006). Rheumatology in Japan, Germany, and Egypt : A Comparison of Medical Practices. 54(2). 51–58. 8 indexed citations
7.
Arbach, Olga, Claudia Metzler, & Angela Gause. (2004). Churg-Strauss-Syndrom: Outcome und Langzeitverlauf von 32 Patienten. Zeitschrift für Rheumatologie. 63(4). 339–40. 1 indexed citations
8.
9.
Gause, Angela, Bernhard Manger, J. R. Kalden, & G. R. Burmester. (2001). Therapie entzündlich-rheumatischer Erkrankungen: Vom Standard in die Zukunft. Der Internist. 42(2). 223–236. 1 indexed citations
10.
Gause, Angela & Claudia Berek. (2001). Role of B Cells in the Pathogenesis of Rheumatoid Arthritis. BioDrugs. 15(2). 73–79. 28 indexed citations
12.
Daus, H., Cem Özbek, Bruno Scheller, et al.. (1998). Lack of Evidence for a Pathogenic Role of <i>Chlamydia pneumoniae</i> and Cytomegalovirus Infection in Coronary Atheroma Formation. Cardiology. 90(2). 83–88. 32 indexed citations
13.
John, Stefan, et al.. (1996). A young woman with a photosensitive pruritic rash on her face and upper trunk. Arthritis & Rheumatism. 39(8). 1419–1422. 9 indexed citations
14.
Zdichavsky, Marty, et al.. (1996). Analysis of bcl-2+ lymphocyte subpopulations in inflammatory synovial infiltrates by a double-immunostaining technique. Rheumatology International. 16(4). 151–157. 3 indexed citations
15.
Bonin, Frederike von, et al.. (1996). Single cell PCR for the analysis of Hodgkin's disease: Four years later. Annals of Oncology. 7. S35–S39. 8 indexed citations
16.
Gause, Angela, et al.. (1994). Impaired Antibody Levels to Tetanus Toxoid and Pneumococcal Polysaccharides in Acute Leukemias. Leukemia & lymphoma. 16(1-2). 89–96. 8 indexed citations
17.
Jung, Wolfram, Stefan Krueger, Christoph Renner, et al.. (1994). Opposite effects of the CD30 ligand are not due to CD30 mutations: Results from cDNA cloning and sequence comparison of the CD30 antigen from different sources. Molecular Immunology. 31(17). 1329–1334. 9 indexed citations
18.
Gause, Angela, W. Jung, Rudolf Schmits, et al.. (1992). Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma. Annals of Oncology. 3. S49–S52. 31 indexed citations
19.
Küppers, Ralf, Angela Gause, & Klaus Rajewsky. (1991). B cells of chronic lymphatic leukemia express V genes in unmutated form. Leukemia Research. 15(6). 487–496. 52 indexed citations
20.
Pfreundschuh, Michael, et al.. (1990). Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T‐cell leukemia and infectious mononucleosis. International Journal of Cancer. 45(5). 869–874. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026